expert roundtables by Boni E. Elewski, MD; Steven R. Feldman, MD, PhD; and Bruce E. Strober, MD, PhD
Biosimilars are available for a variety of inflammatory diseases, promising to lower costs substantially in aligned payor systems. Our featured exp......READ MORE
With respect to topical therapy for plaque psoriasis, individualizing treatment draws on factors such as the location of the skin lesions, the pati......READ MORE
clinical topic updates by Bruce E. Strober, MD, PhD
Research on the microbiome and its role in psoriatic disease continues to unfold. Our featured expert integrates emerging findings with the existin......READ MORE
expert roundtables by Boni E. Elewski, MD; Steven R. Feldman, MD, PhD; and Bruce E. Strober, MD, PhD
In the treatment of plaque psoriasis, small-molecule drugs such as apremilast are not as effective as the injectable therapies that target the inte......READ MORE
expert roundtables by Boni E. Elewski, MD; Steven R. Feldman, MD, PhD; and Bruce E. Strober, MD, PhD
Recent progress in targeted biologic therapies for plaque psoriasis reflects an understanding of the crucial role of the interleukin-23 (IL-23)/IL-......READ MORE
patient care perspectives by Bruce E. Strober, MD, PhD
Patients with psoriasis can be screened for psoriatic arthritis relatively quickly, using a series of questions. Both the presence of joint involve......READ MORE
